Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exocyst complex component 6 (EXOC6) is a protein encoded by the EXOC6 gene in humans and is a critical part of the exocyst complex, a conserved eight-subunit protein complex required for targeting and tethering vesicles to the plasma membrane during exocytosis. EXOC6 is highly homologous to the yeast SEC15 protein, essential for vesicular trafficking from the Golgi apparatus to the cell surface. In humans, it plays important roles in the docking of secretory vesicles with fusion sites at the cell surface. EXOC6’s function is crucial for processes such as the establishment of cell polarity and formation of the apical membrane during epithelial tissue development. Mutations or deletions affecting EXOC6 are implicated in diseases such as nonsyndromic optic nerve aplasia and have been associated with syndromes affecting organ development and function[1][3][4][5][10]. Note: No currently approved drugs target EXOC6 directly, and it is not considered a typical drug target (such as a receptor, enzyme, or transporter) but rather a part of a cytosolic vesicle tethering complex essential for basic cellular function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exocyst complex component 6 (EXOC6).